The immunofluorescence of CTLs and GB in the tumour tissues showed that IPLD-treated tumours did have much higher contents of CD8+ CTLs and GB (Fig. 6h), which were 4.7-fold (Fig. 6i) and 4.1-fold (Fig. 6j) of those in the PLD-treated tumours. This evidence concerns the gene CD8A and neoplasm.